The vast majority of people wont be on a GLP-1 forever
Research studies have highlighted the importance of combining online weight management programs with additional support
Lancet 390 , 26272642 (2017)
Tirzepatide enhances insulin sensitivity, lowers glucagon levels, and reduces post-meal glucose excursions
Overall, there are no major significant safety concerns, Tronieri says
While Eli Lilly and Company includes warning labels about common side effects of their dulaglutide medication, the language on the label may not have provided adequate warnings about severe health risks such as stomach paralysis, intestinal blockages, bowel obstruction, or frequent and excessive vomiting